Epidermal growth factor receptor (EGFR), and anaplastic lymphoma kinase (ALK), are important oncogenic drivers in non-small-cell lung cancer (NSCLC) [2], and other oncogenic drivers in NSCLC, such as ROS1 and KRAS, have also been found [3, 4]. Here, ALK is linked to non-small cell lung carcinoma.